Participated · Series A · Nov 2024

Synapticure is a patient- and caregiver-founded virtual care provider offering nationwide access to expert neurologists, cutting-edge treatments and clinical trials, wraparound care coordination, and behavioral health support for neurodegenerative diseases. Since its launch in 2022 the company has grown to serve several thousand patients across the United States as a specialty virtual care platform for cognitive, neuromuscular, and movement disorders. Synapticure operates a single, standardized clinical operation across all 50 states, including in‑home research capacity, and was selected as a CMS GUIDE provider in all 50 states. The company reports it can provide appointments within two weeks and partners with ACOs, health systems, and health plans to lower costs and improve quality of life. Synapticure plans to use new funding to expand partnerships with providers and payers, invest in its proprietary technology platform (including AI-enabled analytics and remote monitoring), fast-track clinical research and trial enrollment, and scale its national medical group. Leadership and founding includes caregiver-advocates Sandra Abrevaya and Brian Wallach. Synapticure is a Chicago-based teleneurology company that provides personalized care for people living with ALS and their families. The company is building a full-stack teleneurology platform that provides access and continuity of care, including personalized care plans developed through testing, data analytics, and consultations with ALS specialists. It is collaborating with ALS clinics across the country, including Massachusetts General Hospital and University of California San Francisco. Founded by Brian Wallach and Sandra Abrevaya, Synapticure's team, board, and advisory board include clinicians and industry leaders across neurology, genetics, and health tech. Synapticure launched with $6M in seed funding and will use the capital to rapidly scale its care platform to people living with ALS across the United States.

Participated · Series B · Apr 2022

Concert Health is a behavioral health medical group that delivers integrated behavioral health services to primary care, pediatrics, and women’s health practices using the evidence-based Collaborative Care model. Its core product is a turnkey service combining an expert clinical team and a technology platform that embeds behavioral health clinicians into existing care teams to improve outcomes for depression and anxiety. The company reports it has served over 27,000 patients to date, with 55% covered by Medicaid or Medicare, and partners with 54 medical groups across 11 states. Concert says its model reduces symptoms, increases medication adherence, and raises patient satisfaction, and the organization plans to expand into Arkansas, Massachusetts, and Washington this quarter while scaling nationwide. The company works with health systems, Federally Qualified Health Centers, Rural Health Clinics, and independent medical groups to reach underserved and vulnerable populations. Concert is headquartered in San Diego and emphasizes improving value-based care outcomes through integrated behavioral health. Concert Health provides turnkey behavioral health services combining expert Behavioral Care Managers, psychiatrists, and a technology platform to embed Collaborative Care Management (CoCM) into primary care and women’s health. Since 2018 the company has scaled partnerships with 44 medical groups and health systems and supports over 800 physicians across seven states. Its model delivers measurable outcomes—over 60% of patients have seen depression or anxiety symptoms reduce by half within the first 90 days. Concert’s services are reimbursed as a covered benefit for Medicare, most commercial insurers, and Medicaid programs in 18 states. The company plans to use new capital to expand its clinical, technology, and commercial teams and rapidly scale services in primary care and women’s health settings. Concert also partners with large systems including CommonSpirit Health to broaden access to its model.

Participated · Series B · Sep 2021

Clever Care Health Plan is a culturally-inclusive Medicare Advantage health plan centered on complete wellness, combining preventive Eastern therapies with Western allopathic care. The company offers comprehensive medical and supplemental benefits, including dental, hearing, vision, and Eastern benefits such as acupuncture, cupping, and herbal supplements. Since its launch in 2020, Clever Care has grown its membership to over 11,000 members. Led by CEO Myong Lee and based in Huntington Beach, California, the company recently added healthcare veteran Karen Walker Johnson to its board. Clever Care intends to use the new funding to expand its network of independent physicians and clinicians, enter new markets, and broaden outreach ahead of the 2024 Annual Enrollment Period. The plan emphasizes community-based, culturally sensitive wellness and care for its members. Clever Care Health Plan operates a Medicare Advantage HMO that integrates comprehensive medical and supplemental benefits with Eastern health and wellness solutions. The plan launched in Southern California in 2020 and positions itself as the first Medicare Advantage plan to offer acupuncture, meditation, herbal supplements, and medical and dental benefits in an integrated model. Its product targets Medicare beneficiaries seeking culturally sensitive, community-based wellness alongside traditional care. Financially, the company completed a Series B funding round of more than $71 million, bringing total capital raised to $96 million. Clever Care intends to use the financing to expand its network of independent physicians and clinicians, enter new markets, and broaden member access to community-based and culturally sensitive care ahead of the 2022 Annual Enrollment Period. Clever Care Health Plan develops affordable, culturally tailored Medicare Advantage plans aimed at improving access for diverse senior populations. The company emphasizes robust provider networks and innovative benefit design to reduce costs and improve member experience. Founders cite language and cultural barriers in existing provider directories and designed the plan to better serve members who need culturally competent care. Clever Care plans to set up a California Medicare Advantage health plan and hire staff across offices in Little Saigon (Orange County) and Arcadia (Los Angeles County). The senior leadership team includes CEO Dave Firdaus, COO Myong Lee, and CFO Hiep Pham, each with extensive managed-care experience. Financially, the company has raised $26 million to date, including a $6 million seed and a $20 million Series A.